Aktis Oncology, Inc. (AKTS) Q3 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Aktis Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.089 -- 00:00:05.191 And welcome to the Acoustics Technology Festival 2023 third quarter 00:00:05.191 -- 00:00:10.752 conference call. As a reminder, this conference call is being recorded. 00:00:10.752 -- 00:00:16.974 At the conclusion of the company's presentation, Acoustics Management will take questions. 00:00:16.974 -- 00:00:22.136 To ask a question, please press star 1 on your keypad to be placed into the 00:00:22.136 -- 00:00:27.217 queue. A replay of the call will be available on the investor relations 00:00:27.217 -- 00:00:30.958 session of the Acoustics website. 00:00:31.513 -- 00:00:35.074 Thank you, Operator, and good morning to everyone on the call. 00:00:35.074 -- 00:00:38.415 Welcome to ACUSTA's third quarter fiscal 2023 00:00:38.415 -- 00:00:44.177 conference call. We are joined today by our founder and CEO, Jeff Scheele, CFO, 00:00:44.177 -- 00:00:49.359 Ken Bowler, and EVP of Business Development, Dave Eichle. 00:00:49.359 -- 00:00:54.441 Before we begin, please note that today's presentation includes forward-looking statements 00:00:54.441 -- 00:00:59.542 about our business outlook. All statements other than statements of historical facts 00:00:59.542 -- 00:01:04.607 included in this conference call such as expectations regarding our strategies and 00:01:04.607 -- 00:01:09.768 operations, including the timing and prospects of product development and customer 00:01:09.768 -- 00:01:14.909 orders and design wins, possible collaborative or partnering relationships, 00:01:14.909 -- 00:01:19.911 litigation matters, and expected financial and operating results, are forward-looking 00:01:19.911 -- 00:01:25.372 statements. Such forward-looking statements are predictions based on the company's expectations 00:01:25.372 -- 00:01:29.980 as of to...